Kate Cronin

As Chief Brand Officer, Kate Cronin is responsible for amplifying Moderna’s story and the promise of mRNA science for patients.

Ms. Cronin joined Moderna from Ogilvy Health, part of WPP plc., where she served as Global CEO. In this role, she led the full spectrum of Ogilvy Health’s core capabilities including public relations and influence, brand strategy, advertising, medical education, market access, and patient and consumer engagement. Additionally, Ms. Cronin grew Ogilvy’s business in the health and wellness arena, encompassing a broad portfolio including pharmaceuticals, consumer health, insurance, hospitals, health technology and medical devices. Ms. Cronin led integrated campaigns involving social, digital, brand and public relations for Ogilvy’s largest, long-term health clients including BMS, Boehringer Ingelheim, Merck and Pfizer.

Prior to her role as CEO, Ms. Cronin held numerous leadership roles within Ogilvy including Global Managing Director, Managing Director of Ogilvy Public Relations’ New York office, and most recently Co-President of Ogilvy Health in the United States. Before her 17-year tenure at Ogilvy, Ms. Cronin was a Partner at Porter Novelli.

Before starting her career in communications, Ms. Cronin conducted research in the field of neurobiology at Cornell University Medical College. She coauthored several research articles focused on learning and memory and published in peer-review publications. Ms. Cronin received a Bachelor of Arts in biology from Smith College.